Matthew B. Klein, CEO, Director at PTC Therapeutics, holds 29.43K shares in ClearPoint Neuro (Ticker: CLPT), holds 225.81K shares in PTC Therapeutics (Ticker: PTCT).
What is the percentage of profitable transactions made by Matthew B. Klein?
The percentage of profitable transactions made by Matthew B. Klein is 50%.
What is the average return per transaction made by Matthew B. Klein?
The average return per transaction made by Matthew B. Klein is -5.80%.
What stocks does Matthew B. Klein hold?
Matthew B. Klein holds: PTCT, CLPT stocks.
What was Matthew B. Klein’s latest transaction?
Matthew B. Klein latest transaction was an Uninformative Buy of $103.09K.
What was Matthew B. Klein's most profitable transaction?
Matthew B. Klein’s most profitable transaction was an Informative Sell of PTCT stock on April 20, 2023. The return on the trade was 52.90%.
What is Matthew B. Klein's role in PTC Therapeutics?
Matthew B. Klein's role in PTC Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.